NAMSA Webinar EU vs. US: Which Market Fits Your Device Strategy?

Where should you launch first? For medical device innovators, choosing between the U.S. and European markets is rarely straightforward. While regulatory requirements often drive early decision-making, successful market entry depends on much more than obtaining approval. Clinical evidence expectations, reimbursement pathways, commercial opportunities, and adoption dynamics can all influence which market offers the best path forward for your technology.

Join NAMSA’s experts as they compare the key factors that shape market entry and commercialization strategies in the U.S. and Europe. Through practical insights and real-world perspectives, we’ll explore how manufacturers can align their regulatory, clinical, reimbursement, and commercial objectives to determine the market strategy that best supports their device and business goals.

Key Learning Objectives:

• Regulatory: FDA vs. EU MDR requirements and timelines
• Commercial: Market opportunities and adoption considerations
• Clinical: Evidence expectations across both regions
• Reimbursement: Navigating market access and payment pathways

More information: EU vs. US: Which Market Fits Your Device Strategy? - NAMSA